Author | Dr Lisa M. Nijm


Rethinking dry eye disease with acute steroid treatment

Loteprednol etabonate suspension 0.25% demonstrates anti-inflammatory action and produces significant improvement in conjunctival hyperaemia and ocular discomfort.

Using acute steroid treatment for dry eye disease

Patients can benefit from short-term, on-label treatment with a novel loteprednol formulation.

Cyclosporine options for dry eye relief have varying tolerabilities

Cyclosporine for dry eye disease appears to be efficacious at all levels and the choice of which formulation to use usually depends on tolerability and affordability. Tolerability hinges primarily on the vehicle, which varies among different products.